amitriptyline has been researched along with Behavior Disorder, Rapid Eye Movement Sleep in 1 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dolso, P | 1 |
Merlino, G | 1 |
Fratticci, L | 1 |
Canesin, R | 1 |
Valiante, G | 1 |
Coccolo, D | 1 |
Gigli, GL | 1 |
1 other study available for amitriptyline and Behavior Disorder, Rapid Eye Movement Sleep
Article | Year |
---|---|
Non-REM hypnic headache: a circadian disorder? A clinical and polysomnographic study.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Chronobiology Disorders; Headache Disorders, Primary | 2007 |